Affinity Asset Advisors, LLC Harpoon Therapeutics, Inc. Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$5.69 - $7.83 $1.42 Million - $1.96 Million
-250,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.88 - $14.0 $1.58 Million - $2.8 Million
200,000 Added 400.0%
250,000 $1.98 Million
Q2 2021

Aug 13, 2021
BUY
$13.81 - $23.25 $414,300 - $697,500
30,000 Added 150.0%
50,000 $694,000
Q1 2021

May 14, 2021
BUY
$17.65 - $24.16 $353,000 - $483,200
20,000 New
20,000 $418,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email